Zobrazeno 1 - 10
of 13
pro vyhledávání: '"R L, Cavanagh"'
Publikováno v:
The American Journal of Digestive Diseases. 4:706-709
A modified Cori4, 13 rat preparation was used to study the effect of concentration on the absorption rates of xylose and glucose from the small intestine. Solutions of 25 per cent and 50 per cent glucose were absorbed at statistically identical rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f9860b0ceb5eaebb9b4845204acb82
https://doi.org/10.1007/bf02232176
https://doi.org/10.1007/bf02232176
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 243(3)
Histamine H2 receptor antagonists have been reported to protect the gastric mucosa of animals and humans against aspirin-induced damage. It is unclear, however, whether this protective effect can be observed at doses less than those needed to markedl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e761986f4f14d0b9f961a37991e39427
https://pubmed.ncbi.nlm.nih.gov/2891837
https://pubmed.ncbi.nlm.nih.gov/2891837
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 220(2)
Butorphanol (levo-N-cyclobutylmethyl-3, 14-dihydroxy morphinan), a potent analgetic agent of the narcotic antagonist type with a low abuse potential in laboratory animals, was evaluated for antitussive activity in unanesthetized guinea-pigs and dogs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9db6f115cfac7c2d9c75d2a86c19910
https://pubmed.ncbi.nlm.nih.gov/952583
https://pubmed.ncbi.nlm.nih.gov/952583
Autor:
J. P. Buyniski, R. L. Cavanagh
Publikováno v:
Alimentary pharmacologytherapeutics. 3(3)
BMY-25368, 1-amino-2-[3-(3-piperidinomethylphenoxy) propylamino]-1-cyclobutene-3,4-dione, a new histamine H2-receptor antagonist, has been compared to ranitidine as an inhibitor of gastric acid secretion in the Heidenhain pouch dog. Intravenous infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27fde1fb5926a4e33016536090d8912c
https://pubmed.ncbi.nlm.nih.gov/2577694
https://pubmed.ncbi.nlm.nih.gov/2577694
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 233(2)
Butorphanol, levo-N-cyclobutylmethyl-3, 14beta-dihydroxy-morphinan, is a new agonist-antagonist type analgetic agent which is 4 times more potent than morphine in experimental animals. Equianalgetic doses of butorphanol and morphine were compared, fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b499fcfbc93df736d41d34b389860011
https://pubmed.ncbi.nlm.nih.gov/686916
https://pubmed.ncbi.nlm.nih.gov/686916
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 220(2)
Butorphanol, a new, totally synthetic morphinan, which is chemically related to naloxone, has been demonstrated to have both analgesic and narcotic antagonist properties. In rodent antiwrithing analgesic tests, butorphanol was 4 to 30 times more pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbc595e205a865a6afd9a8584f319f3b
https://pubmed.ncbi.nlm.nih.gov/60089
https://pubmed.ncbi.nlm.nih.gov/60089
Publikováno v:
Journal of medicine. 10(4)
Butorphanol, levo-N-cyclobutylmethyl-3,14 beta-dihydroxy-morphinan, is a new agonist-antagonist type analgetic agent which is 4 to 8 times more potent than morphine in experimental animals and man. Butorphanol and morphine were evaluated in mice and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ff5f362073a3e37fcf98867f5b4f527
https://pubmed.ncbi.nlm.nih.gov/43349
https://pubmed.ncbi.nlm.nih.gov/43349
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 224(1)
Etintidine is a competitive antagonist of histamine H2-receptors in the isolated spontaneously beating guinea-pig right atrium with a pA2 value of 6.6 relative to values of 6.2, 6.7 and 7.3 for cimetidine, ranitidine and tiotidine, respectively. Low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d609d71cc6096726ae82315a00888de
https://pubmed.ncbi.nlm.nih.gov/6129316
https://pubmed.ncbi.nlm.nih.gov/6129316
Autor:
C F, Barfknecht, J F, Caputo, M B, Tobin, D C, Dyer, R T, Standirdge, H G, Howell, W R, Goodwin, R A, Partyka, J A, Gylys, R L, Cavanagh
Publikováno v:
NIDA research monograph. (22)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6367c75ef09dac6b12e18ddea6bc406
https://pubmed.ncbi.nlm.nih.gov/101880
https://pubmed.ncbi.nlm.nih.gov/101880
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 194(2)
The effect of 6-methyl-1,2,3,5-tetrahydroimidazo[2,1-b] quinazolin-2-one hydrochloride monohydrate (BL-3459) on platelet function and experimental thrombosis was evaluated in a series of in vitro, ex vivo and in vivo animal experiments. Potent inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::764dc1f18ed397d5f06d42b655dd02dc
https://pubmed.ncbi.nlm.nih.gov/1151769
https://pubmed.ncbi.nlm.nih.gov/1151769